Xeris Biopharma Holdings (XERS) Capital Expenditures (2020 - 2021)
Xeris Biopharma Holdings' (XERS) quarterly Capital Expenditures came in at $131000.0 in Q4 2021, down 41.78% YoY from $225000.0 in Q4 2020, and down 41.78% on a QoQ basis from $225000.0 in Q4 2020.
Xeris Biopharma Holdings (XERS) Capital Expenditures (2020 - 2021) Analysis & Trends
Xeris Biopharma Holdings (XERS) has 2 years of Capital Expenditures data on file, last reported at $131000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Xeris Biopharma Holdings | 1.51 Bn | 1.39 Bn | 79.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 131,000.00 |
| Dec 31, 2021 | 131,000.00 |
| Dec 31, 2020 | 225,000.00 |
| Dec 31, 2020 | 225,000.00 |